CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570)
The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. The company's vision is to be a leading provider of solutions i...Show all
Company (IPO / Went public)
Phone: 973-290-6000
8 Sylvan Way
Parsippany, 07054
New Jersey, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| The Medicines Company | $100.8M | May 7, 2001 |
| Cogentus Pharmaceuticals | $168M | Nov 21, 2008 |
| NanoString Technologies | $158.8M | Jun 26, 2013 |
| See all 14 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Methods for treating bacterial infections using oritavancin and polymyxins | Aug 28, 2014 | Oct 03, 2017 | Patent |
| Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Jun 21, 2016 | Jul 11, 2017 | Patent |
| Methods of treating bacterial infections using oritavancin | Apr 26, 2010 | Jun 20, 2017 | Patent |
| High purity oritavancin and method of producing same | Jul 16, 2015 | May 16, 2017 | Patent |
| Trypsin-like serine protease inhibitors, and their preparation and use | Oct 31, 2013 | Apr 04, 2017 | Patent |
